Three compounds of an aminothiol family of iron chelators were examined for
activity against trypomastigote (human) and epimastigote (vector) forms of
Trypanosoma cruzi tetraethyl and tetramethyl derivatives of ethane-1,2-bis
(N-1-amino-3-ethyl butyl-3-thiol) (BAT-TE and BAT-TM) and N',N',N'-tris-(2
-methyl-2-mercaptopriopyl)-1.4.7-triaza-cyclonane (TAT). BAT-TE at 270 mu M
completely arrested the growth of trypomastigote forms in mouse blood stor
ed at 4 degrees C for 24 h (IC50 67.7 +/- 7 mu M), while BAT-TM arrested gr
owth at 630 mu M (IC50 158 +/- 17 mu M) and TAT at concentrations >800 mu M
(IC50 415 +/- 55 mu M). In T. cruzi-infected mice, BAT-TE and BAT-TM had n
o anti-trypanosomal activity in doses up to 200 mg/kg, whether the route of
administration was intraperitoneal or oral. and TAT was not tested due to
insufficient quantity. TAT had an IC50 of 52 +/- 7 mu M against the epimast
igote forms while BAT-TM and BAT-TE were inhibitory only at concentrations
>250 mu M. The trypanocidal activity of BAT derivatives in blood stored at
4 degrees C makes these compounds potential candidates for the purpose of c
learing donated blood of trypomastigotes. (C) 2000 Academic Press.